Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
Net Income (Common)
Prothena Corporation PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prothena Corporation PLC
NASDAQ:PRTA
|
Net Income (Common)
-$147m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
Alkermes Plc
NASDAQ:ALKS
|
Net Income (Common)
$355.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Net Income (Common)
-$52.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Net Income (Common)
-$207.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prothena Corporation PLC's Net Income (Common)?
Net Income (Common)
-147m
USD
Based on the financial report for Dec 31, 2023, Prothena Corporation PLC's Net Income (Common) amounts to -147m USD.
What is Prothena Corporation PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-14%
Over the last year, the Net Income (Common) growth was -26%. The average annual Net Income (Common) growth rates for Prothena Corporation PLC have been -10% over the past three years , 1% over the past five years , and -14% over the past ten years .